Clik here to view.
Otsuka Pharmaceutical to Acquire Neurovance, Inc.
TOKYO Otsuka Pharmaceutical Co., Ltd. (OPC) today announces an agreement with Neurovance, Inc. (Neurovance) under which OPC has agreed to acquire Neurovance, a privately held, venture-funded,...
View ArticleClik here to view.
The UK High Court of Justice (Patents) Rules in Fujifilm Kyowa Kirin...
TOKYO FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd. (President and CEO: Hideaki Nomura; “Fujifilm Kyowa Kirin Biologics”) today announced that on March 3, 2017, the UK High Court of Justice ruled in...
View ArticleClik here to view.
レブラミド（レナリドミド）が初発多発性骨髄腫患者の自家幹細胞移植後の維持療法を目的とした単剤療法として欧州委員会より承認される
スイス・ブードリー （ビジネスワイヤ） — セルジーン・コーポレーション（NASDAQ:...
View ArticleClik here to view.
大腸手術中におけるMasimo PVi®モニタリングの有用性を評価する新研究
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ （NASDAQ: MASI）は本日、大腸手術を受ける低リスク患者を対象に最近実施された研究の結果を発表しました。研究で研究者らは、侵襲的手段である経食道ドップラーとの比較で、輸液管理の指針としての非侵襲的・連続的Masimo...
View ArticleClik here to view.
Richard L. Wang Named Chief Executive Officer of Fosun Kite Biotechnology...
SANTA MONICA, Calif. Kite Pharma, Inc., (Nasdaq:KITE) today announced that Richard L. Wang, Ph.D. will be appointed Chief Executive Officer of Fosun Kite Biotechnology Co., Ltd, the company’s 50/50...
View ArticleClik here to view.
オクタファルマ・グループが2016年業績を発表、売上高は16億ユーロ、営業利益は3億8300万ユーロを記録
スイス・ラッヘン （ビジネスワイヤ） — オクタファルマ・グループが発表した2016年業績は過去最高となり、売上高は2015年に比べて8700万ユーロ、5.8%の増加となる16億ユーロに達しました。...
View ArticleClik here to view.
GI Dynamics Announces New Scientific Advisory Board and Board’s First Two...
BOSTON & SYDNEY GI Dynamics®, Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier® in Europe, the Middle East and South America for patients with type 2 diabetes and...
View ArticleClik here to view.
Avita Medical Announces Last Patient Visit in U.S. Pivotal Trial
VALENCIA, Calif. & PERTH, Australia & CAMBRIDGE, England Avita Medical Limited (ASX:AVH; OTCQX:AVMXY), a regenerative medicine company focused on the treatment of wounds and skin defects,...
View ArticleClik here to view.
Multiple Abstracts Concerning MIS416 Mechanism of Action Accepted for...
SYDNEY Innate Immunotherapeutics Limited (ASX Code: IIL), together with a number of Australian, Canadian, and Danish scientific collaborators, has had multiple abstracts accepted for presentation at...
View ArticleClik here to view.
Waters ACQUITY QDa 質量検出器が Pittcon Today Excellence 金賞を受賞
シカゴ （ビジネスワイヤ） — ウォーターズコーポレーション (NYSE:WAT) の ACQUITY QDa 質量検出器が、Pittcon2017 Conference and Expo （分析化学と応用分光学に関するピッツバーグ会議）で Pittcon Today Excellence 金賞を受賞しました。 このSmart News...
View ArticleClik here to view.
GI Dynamics Announces Scientific Advisory Board Members to Further Scientific...
BOSTON & SYDNEY GI Dynamics®, Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier® in Europe, the Middle East and South America for patients with type 2 diabetes and...
View ArticleClik here to view.
Mitsubishi Electric Finishes Construction of Superconducting-magnet Plant
TOKYO Mitsubishi Electric Corporation (TOKYO:6503) announced that it has completed construction of a superconducting-magnet manufacturing plant at its Transmission and Distribution Systems Center in...
View ArticleClik here to view.
Sosei Subsidiary Heptares and Daiichi Sankyo to Discover and Develop Novel,...
TOKYO Sosei Group Corporation (“Sosei”; TSE Mothers Index:4565) reported that its subsidiaries, Heptares Therapeutics (“Heptares”) has announced that it have entered into a drug discovery and...
View ArticleClik here to view.
Protalex Significantly Strengthens Global Intellectual Property Portfolio for...
FLORHAM PARK, N.J. Protalex, Inc. (OTCQB:PRTX), a clinical-stage biopharmaceutical company, announces that the Company has been granted several key patents for PRTX-100, the Company’s highly...
View ArticleClik here to view.
TA Associates Announces Investment in Ideal Cures
BOSTON & MUMBAI, India TA Associates, a leading global growth private equity firm, today announced it has completed an investment in Ideal Cures Private Limited, a supplier of ready-to-use...
View ArticleClik here to view.
Enanta Announces Japanese Ministry of Health, Labour and Welfare Grants...
WATERTOWN, Mass. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver...
View ArticleClik here to view.
AllAccem Announces Human Dental Product Presentation at the 2017...
SAN CARLOS, Calif. AllAccem, Inc., a pharmaceutical and medical device products developer and manufacturer, announced today that Karin M. Hold, PhD is presenting the poster titled “Biocompatibility...
View ArticleClik here to view.
SpinalCyte的里程碑式试验完成首例成纤维细胞注射以促使椎间盘再生
休斯敦 (美国商业资讯) — SpinalCyte, LLC是一家总部位于美国德州的组织工程技术公司，专注于采用人类皮肤成纤维细胞进行椎间盘髓核的再生。该公司今天宣布，已完成首例成纤维细胞注射以促使椎间盘再生。CybroCell是首个用于治疗退行性椎间盘疾病的皮肤成纤维细胞产品。该手术采用局部麻醉，在15分钟以内完成。患者未出现并发症，在1小时内出院。 SpinalCyte首席执行官Pete...
View ArticleClik here to view.
Medical Device Company Visioneering Technologies Successfully Raises $33.3...
ALPHARETTA, Ga. Visioneering Technologies, Inc. (VTI), a US-based medical device company engaged in the design, manufacture, sale and distribution of its proprietary NaturalVue™ Multifocal 1 Day...
View ArticleClik here to view.
Avita Announces Receipt of $975K R&D Tax Incentive
VALENCIA, Calif. & PERTH, Australia & CAMBRIDGE, England Avita Medical Limited (ASX:AVH) (OTCQX:AVMXY), a regenerative medicine company focused on the treatment of wounds and skin defects,...
View Article